Literature DB >> 21916702

A longitudinal study of use of an interactive health communication system.

Jeong Yeob Han1.   

Abstract

This study analyzes individuals' transaction log data as patients engage in an interactive health communication system (IHCS) and reports on how changes in searching and browsing behaviors predict their psychological and emotional quality of life during a cancer experience. What the results most strongly indicate about effective IHCS usage in accounting for various benefits is that it depends on how a patient uses the system. That is, improvements in a patient's status were linked to her commitment to use IHCS services over weeks of time, through either consistency or an increase in searching and browsing behaviors.

Entities:  

Mesh:

Year:  2011        PMID: 21916702     DOI: 10.1080/10410236.2011.578334

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  4 in total

1.  How Cancer Patients Use and Benefit from an Interactive Cancer Communication System.

Authors:  Jeong Yeob Han; Robert Hawkins; Timothy Baker; Dhavan V Shah; Suzanne Pingree; David H Gustafson
Journal:  J Health Commun       Date:  2017-09-18

2.  Communication competence, psychological well-being, and the mediating role of coping efforts among women with breast cancer: cross-sectional and longitudinal evidence.

Authors:  Minsun Shim; Laura M Mercer Kollar; Linda J Roberts; David H Gustafson
Journal:  Women Health       Date:  2015-03-20

3.  Lurking as an active participation process: a longitudinal investigation of engagement with an online cancer support group.

Authors:  Jeong Yeob Han; Jiran Hou; Eunkyung Kim; David H Gustafson
Journal:  Health Commun       Date:  2013-12-17

4.  Assessment of quality of life in women five years after breast cancer surgery, members of Breast Cancer Self-Help Groups - non-randomized, cross-sectional study.

Authors:  Magdalena Sowa; Iwona Głowacka-Mrotek; Ewelina Monastyrska; Tomasz Nowikiewicz; Magdalena Mackiewicz-Milewska; Wojciech Hagner; Wojciech Zegarski
Journal:  Contemp Oncol (Pozn)       Date:  2018-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.